ArticleFrontiers in oncology2023

β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion.

YingHao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.